Notebook

ANTSY ANTIBIOTICS Humans didn't invent self-medication. Ants got into the act 50 million years ago. The attine ants are expert gardeners, cultivating edible fungi in subterranean "mushroom farms" on food harvested above ground. The most famous attines are the leaf cutters, whose superorganismlike colonies of several million ants are organized into functional castes led by a queen (B. Hölldobler and E.O. Wilson, Journey to the Ants, Harvard University Press, 1994). Their prodigious harvest

Written byBarry Palevitz
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

ANTSY ANTIBIOTICS Humans didn't invent self-medication. Ants got into the act 50 million years ago. The attine ants are expert gardeners, cultivating edible fungi in subterranean "mushroom farms" on food harvested above ground. The most famous attines are the leaf cutters, whose superorganismlike colonies of several million ants are organized into functional castes led by a queen (B. Hölldobler and E.O. Wilson, Journey to the Ants, Harvard University Press, 1994). Their prodigious harvesting of leaves to feed the fungi, and the soil they turn over building the colony, are important in tropical ecosystem dynamics. But there's a fly in the ointment: Another fungus, called Escovopsis, parasitizes the farms. What's a poor ant queen to do? According to graduate student Cameron Currie and colleagues at the Smithsonian Tropical Research Institute, Panama, and the University of Toronto, Canada, like many a parent she insists on antibiotics (C.R. Currie et al., "Fungus-growing ants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies